世界の注射用レボカルニチン市場予測2023-2029:注射剤、凍結乾燥粉末

【英語タイトル】Levocarnitine for Injection Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2485)・商品コード:MMG23FB2485
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:78
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の注射用レボカルニチン市場規模と予測を収録しています。・世界の注射用レボカルニチン市場:売上、2018年-2023年、2024年-2029年
・世界の注射用レボカルニチン市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用レボカルニチン市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

注射用レボカルニチンのグローバル主要企業は、EPHARM、REYOUNG、Shandong Qidu、Guangdong Jianxin、Hainan Shuangcheng Pharmaceutical、Sigma-Tau Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、注射用レボカルニチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の注射用レボカルニチン市場:タイプ別、2018年-2023年、2024年-2029年
世界の注射用レボカルニチン市場:タイプ別市場シェア、2022年
・注射剤、凍結乾燥粉末

世界の注射用レボカルニチン市場:用途別、2018年-2023年、2024年-2029年
世界の注射用レボカルニチン市場:用途別市場シェア、2022年
・病院、薬局、その他

世界の注射用レボカルニチン市場:地域・国別、2018年-2023年、2024年-2029年
世界の注射用レボカルニチン市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における注射用レボカルニチンのグローバル売上、2018年-2023年
・主要企業における注射用レボカルニチンのグローバル売上シェア、2022年
・主要企業における注射用レボカルニチンのグローバル販売量、2018年-2023年
・主要企業における注射用レボカルニチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
EPHARM、REYOUNG、Shandong Qidu、Guangdong Jianxin、Hainan Shuangcheng Pharmaceutical、Sigma-Tau Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
注射用レボカルニチン市場の定義
市場セグメント
世界の注射用レボカルニチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用レボカルニチン市場規模
世界の注射用レボカルニチン市場規模:2022年 VS 2029年
世界の注射用レボカルニチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用レボカルニチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用レボカルニチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:注射剤、凍結乾燥粉末
注射用レボカルニチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、薬局、その他
注射用レボカルニチンの用途別グローバル売上・予測

・地域別市場分析
地域別注射用レボカルニチン市場規模 2022年と2029年
地域別注射用レボカルニチン売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
EPHARM、REYOUNG、Shandong Qidu、Guangdong Jianxin、Hainan Shuangcheng Pharmaceutical、Sigma-Tau Pharmaceuticals

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Levocarnitine for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Levocarnitine for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Levocarnitine for Injection Overall Market Size
2.1 Global Levocarnitine for Injection Market Size: 2022 VS 2029
2.2 Global Levocarnitine for Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Levocarnitine for Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Levocarnitine for Injection Players in Global Market
3.2 Top Global Levocarnitine for Injection Companies Ranked by Revenue
3.3 Global Levocarnitine for Injection Revenue by Companies
3.4 Global Levocarnitine for Injection Sales by Companies
3.5 Global Levocarnitine for Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Levocarnitine for Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Levocarnitine for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Levocarnitine for Injection Players in Global Market
3.8.1 List of Global Tier 1 Levocarnitine for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Levocarnitine for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Levocarnitine for Injection Market Size Markets, 2022 & 2029
4.1.2 Injection
4.1.3 Freeze-dried Powder
4.2 By Type – Global Levocarnitine for Injection Revenue & Forecasts
4.2.1 By Type – Global Levocarnitine for Injection Revenue, 2018-2023
4.2.2 By Type – Global Levocarnitine for Injection Revenue, 2024-2029
4.2.3 By Type – Global Levocarnitine for Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Levocarnitine for Injection Sales & Forecasts
4.3.1 By Type – Global Levocarnitine for Injection Sales, 2018-2023
4.3.2 By Type – Global Levocarnitine for Injection Sales, 2024-2029
4.3.3 By Type – Global Levocarnitine for Injection Sales Market Share, 2018-2029
4.4 By Type – Global Levocarnitine for Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Levocarnitine for Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Others
5.2 By Application – Global Levocarnitine for Injection Revenue & Forecasts
5.2.1 By Application – Global Levocarnitine for Injection Revenue, 2018-2023
5.2.2 By Application – Global Levocarnitine for Injection Revenue, 2024-2029
5.2.3 By Application – Global Levocarnitine for Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Levocarnitine for Injection Sales & Forecasts
5.3.1 By Application – Global Levocarnitine for Injection Sales, 2018-2023
5.3.2 By Application – Global Levocarnitine for Injection Sales, 2024-2029
5.3.3 By Application – Global Levocarnitine for Injection Sales Market Share, 2018-2029
5.4 By Application – Global Levocarnitine for Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Levocarnitine for Injection Market Size, 2022 & 2029
6.2 By Region – Global Levocarnitine for Injection Revenue & Forecasts
6.2.1 By Region – Global Levocarnitine for Injection Revenue, 2018-2023
6.2.2 By Region – Global Levocarnitine for Injection Revenue, 2024-2029
6.2.3 By Region – Global Levocarnitine for Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Levocarnitine for Injection Sales & Forecasts
6.3.1 By Region – Global Levocarnitine for Injection Sales, 2018-2023
6.3.2 By Region – Global Levocarnitine for Injection Sales, 2024-2029
6.3.3 By Region – Global Levocarnitine for Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Levocarnitine for Injection Revenue, 2018-2029
6.4.2 By Country – North America Levocarnitine for Injection Sales, 2018-2029
6.4.3 US Levocarnitine for Injection Market Size, 2018-2029
6.4.4 Canada Levocarnitine for Injection Market Size, 2018-2029
6.4.5 Mexico Levocarnitine for Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Levocarnitine for Injection Revenue, 2018-2029
6.5.2 By Country – Europe Levocarnitine for Injection Sales, 2018-2029
6.5.3 Germany Levocarnitine for Injection Market Size, 2018-2029
6.5.4 France Levocarnitine for Injection Market Size, 2018-2029
6.5.5 U.K. Levocarnitine for Injection Market Size, 2018-2029
6.5.6 Italy Levocarnitine for Injection Market Size, 2018-2029
6.5.7 Russia Levocarnitine for Injection Market Size, 2018-2029
6.5.8 Nordic Countries Levocarnitine for Injection Market Size, 2018-2029
6.5.9 Benelux Levocarnitine for Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Levocarnitine for Injection Revenue, 2018-2029
6.6.2 By Region – Asia Levocarnitine for Injection Sales, 2018-2029
6.6.3 China Levocarnitine for Injection Market Size, 2018-2029
6.6.4 Japan Levocarnitine for Injection Market Size, 2018-2029
6.6.5 South Korea Levocarnitine for Injection Market Size, 2018-2029
6.6.6 Southeast Asia Levocarnitine for Injection Market Size, 2018-2029
6.6.7 India Levocarnitine for Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Levocarnitine for Injection Revenue, 2018-2029
6.7.2 By Country – South America Levocarnitine for Injection Sales, 2018-2029
6.7.3 Brazil Levocarnitine for Injection Market Size, 2018-2029
6.7.4 Argentina Levocarnitine for Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Levocarnitine for Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Levocarnitine for Injection Sales, 2018-2029
6.8.3 Turkey Levocarnitine for Injection Market Size, 2018-2029
6.8.4 Israel Levocarnitine for Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Levocarnitine for Injection Market Size, 2018-2029
6.8.6 UAE Levocarnitine for Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 EPHARM
7.1.1 EPHARM Company Summary
7.1.2 EPHARM Business Overview
7.1.3 EPHARM Levocarnitine for Injection Major Product Offerings
7.1.4 EPHARM Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.1.5 EPHARM Key News & Latest Developments
7.2 REYOUNG
7.2.1 REYOUNG Company Summary
7.2.2 REYOUNG Business Overview
7.2.3 REYOUNG Levocarnitine for Injection Major Product Offerings
7.2.4 REYOUNG Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.2.5 REYOUNG Key News & Latest Developments
7.3 Shandong Qidu
7.3.1 Shandong Qidu Company Summary
7.3.2 Shandong Qidu Business Overview
7.3.3 Shandong Qidu Levocarnitine for Injection Major Product Offerings
7.3.4 Shandong Qidu Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.3.5 Shandong Qidu Key News & Latest Developments
7.4 Guangdong Jianxin
7.4.1 Guangdong Jianxin Company Summary
7.4.2 Guangdong Jianxin Business Overview
7.4.3 Guangdong Jianxin Levocarnitine for Injection Major Product Offerings
7.4.4 Guangdong Jianxin Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.4.5 Guangdong Jianxin Key News & Latest Developments
7.5 Hainan Shuangcheng Pharmaceutical
7.5.1 Hainan Shuangcheng Pharmaceutical Company Summary
7.5.2 Hainan Shuangcheng Pharmaceutical Business Overview
7.5.3 Hainan Shuangcheng Pharmaceutical Levocarnitine for Injection Major Product Offerings
7.5.4 Hainan Shuangcheng Pharmaceutical Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.5.5 Hainan Shuangcheng Pharmaceutical Key News & Latest Developments
7.6 Sigma-Tau Pharmaceuticals
7.6.1 Sigma-Tau Pharmaceuticals Company Summary
7.6.2 Sigma-Tau Pharmaceuticals Business Overview
7.6.3 Sigma-Tau Pharmaceuticals Levocarnitine for Injection Major Product Offerings
7.6.4 Sigma-Tau Pharmaceuticals Levocarnitine for Injection Sales and Revenue in Global (2018-2023)
7.6.5 Sigma-Tau Pharmaceuticals Key News & Latest Developments
8 Global Levocarnitine for Injection Production Capacity, Analysis
8.1 Global Levocarnitine for Injection Production Capacity, 2018-2029
8.2 Levocarnitine for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Levocarnitine for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Levocarnitine for Injection Supply Chain Analysis
10.1 Levocarnitine for Injection Industry Value Chain
10.2 Levocarnitine for Injection Upstream Market
10.3 Levocarnitine for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Levocarnitine for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Levocarnitine for Injection in Global Market
Table 2. Top Levocarnitine for Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Levocarnitine for Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Levocarnitine for Injection Revenue Share by Companies, 2018-2023
Table 5. Global Levocarnitine for Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Levocarnitine for Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Levocarnitine for Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Levocarnitine for Injection Product Type
Table 9. List of Global Tier 1 Levocarnitine for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Levocarnitine for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Levocarnitine for Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Levocarnitine for Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Levocarnitine for Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Levocarnitine for Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Levocarnitine for Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Levocarnitine for Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Levocarnitine for Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Levocarnitine for Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Levocarnitine for Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Levocarnitine for Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Levocarnitine for Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Levocarnitine for Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Levocarnitine for Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Levocarnitine for Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Levocarnitine for Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Levocarnitine for Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Levocarnitine for Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Levocarnitine for Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Levocarnitine for Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Levocarnitine for Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Levocarnitine for Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Levocarnitine for Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Levocarnitine for Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Levocarnitine for Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Levocarnitine for Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Levocarnitine for Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Levocarnitine for Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Levocarnitine for Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Levocarnitine for Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Levocarnitine for Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Levocarnitine for Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Levocarnitine for Injection Sales, (K Units), 2024-2029
Table 46. EPHARM Company Summary
Table 47. EPHARM Levocarnitine for Injection Product Offerings
Table 48. EPHARM Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. EPHARM Key News & Latest Developments
Table 50. REYOUNG Company Summary
Table 51. REYOUNG Levocarnitine for Injection Product Offerings
Table 52. REYOUNG Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. REYOUNG Key News & Latest Developments
Table 54. Shandong Qidu Company Summary
Table 55. Shandong Qidu Levocarnitine for Injection Product Offerings
Table 56. Shandong Qidu Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Shandong Qidu Key News & Latest Developments
Table 58. Guangdong Jianxin Company Summary
Table 59. Guangdong Jianxin Levocarnitine for Injection Product Offerings
Table 60. Guangdong Jianxin Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Guangdong Jianxin Key News & Latest Developments
Table 62. Hainan Shuangcheng Pharmaceutical Company Summary
Table 63. Hainan Shuangcheng Pharmaceutical Levocarnitine for Injection Product Offerings
Table 64. Hainan Shuangcheng Pharmaceutical Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Hainan Shuangcheng Pharmaceutical Key News & Latest Developments
Table 66. Sigma-Tau Pharmaceuticals Company Summary
Table 67. Sigma-Tau Pharmaceuticals Levocarnitine for Injection Product Offerings
Table 68. Sigma-Tau Pharmaceuticals Levocarnitine for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sigma-Tau Pharmaceuticals Key News & Latest Developments
Table 70. Levocarnitine for Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Levocarnitine for Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Levocarnitine for Injection Production by Region, 2018-2023 (K Units)
Table 73. Global Levocarnitine for Injection Production by Region, 2024-2029 (K Units)
Table 74. Levocarnitine for Injection Market Opportunities & Trends in Global Market
Table 75. Levocarnitine for Injection Market Drivers in Global Market
Table 76. Levocarnitine for Injection Market Restraints in Global Market
Table 77. Levocarnitine for Injection Raw Materials
Table 78. Levocarnitine for Injection Raw Materials Suppliers in Global Market
Table 79. Typical Levocarnitine for Injection Downstream
Table 80. Levocarnitine for Injection Downstream Clients in Global Market
Table 81. Levocarnitine for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Levocarnitine for Injection Segment by Type in 2022
Figure 2. Levocarnitine for Injection Segment by Application in 2022
Figure 3. Global Levocarnitine for Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Levocarnitine for Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Levocarnitine for Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Levocarnitine for Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Levocarnitine for Injection Revenue in 2022
Figure 9. By Type - Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Levocarnitine for Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Levocarnitine for Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Levocarnitine for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Levocarnitine for Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 23. US Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 28. Germany Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 37. China Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 44. Brazil Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Levocarnitine for Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Levocarnitine for Injection Sales Market Share, 2018-2029
Figure 48. Turkey Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Levocarnitine for Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Levocarnitine for Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Levocarnitine for Injection by Region, 2022 VS 2029
Figure 54. Levocarnitine for Injection Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の注射用レボカルニチン市場予測2023-2029:注射剤、凍結乾燥粉末] (コード:MMG23FB2485)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の注射用レボカルニチン市場予測2023-2029:注射剤、凍結乾燥粉末]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆